Literature DB >> 30604893

Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.

Xin Lu1, Xiaohan Zhang1, Yongjian Zhang2, Kun Zhang1, Chao Zhan2, Xiuyun Shi1, Yiqun Li1, Jianxiang Zhao1, Yunfan Bai1, Yu Wang1, Huan Nie1, Yu Li1.   

Abstract

The carnitine shuttle system (CSS) plays a crucial role in the transportation of fatty acyls during fatty acid β-oxidation for energy supplementation, especially in cases of high energy demand, such as in cancer. In this study, to systematically characterize alterations of the CSS in hepatocellular carcinoma (HCC), acylcarnitine metabolic profiling was carried out on 80 pairs of HCC tissues and adjacent noncancerous tissues (ANTs) by using ultra-performance liquid chromatography coupled to mass spectrometry. Twenty-four acylcarnitines classified into five categories were identified and characterized between HCCs and ANTs. Notably, increased saturated long-chain acylcarnitines (LCACs) and decreased short- and medium-chain acylcarnitines (S/MCACs) were simultaneously observed in HCC samples. Subsequent correlation network and heatmap analysis indicated low correlations between LCACs and S/MCACs. The mRNA and protein expressions of carnitine palmitoyltransferase 2 (CPT2) was significantly downregulated in HCC samples, whereas CPT1A expression was not significantly changed. Correspondingly, the relative levels of S/MCACs were reduced and those of LCACs were increased in BEL-7402/CPT2-knockdown cells compared to negative controls. Both results suggested that decreased shuttling efficiency in HCC might be associated with downregulation of CPT2. In addition, decreases in the mRNA expression of acetyl-CoA acyltransferase 2 were also observed in HCC tissues and BEL-7402/CPT2-knockdown cells, suggesting potential low β-oxidation efficiency, which was consistent with the increased expression of stearoyl-CoA desaturase 1 in both samples. The systematic strategy applied in our study illustrated decreased shuttling efficiency of the carnitine shuttle system in HCC and can provide biologists with an in-depth understanding of β-oxidation in HCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CPT2; liver cancer; metabolomics; β-oxidation

Mesh:

Substances:

Year:  2019        PMID: 30604893     DOI: 10.1002/mc.22967

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  A HILIC-MS/MS method development and validation for the quantitation of 13 acylcarnitines in human serum.

Authors:  Thomas Meikopoulos; Olga Deda; Efstratios Karagiannidis; Georgios Sianos; Georgios Theodoridis; Helen Gika
Journal:  Anal Bioanal Chem       Date:  2022-02-17       Impact factor: 4.142

2.  Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.

Authors:  Kenichiro Enooku; Hayato Nakagawa; Naoto Fujiwara; Mayuko Kondo; Tatsuya Minami; Yujin Hoshida; Junji Shibahara; Ryosuke Tateishi; Kazuhiko Koike
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

3.  Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis.

Authors:  Da Jung Kim; Eun Ju Cho; Kyung-Sang Yu; In-Jin Jang; Jung-Hwan Yoon; Taesung Park; Joo-Youn Cho
Journal:  Cancers (Basel)       Date:  2019-10-06       Impact factor: 6.639

4.  Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME).

Authors:  Joanna Bogusiewicz; Katarzyna Burlikowska; Karol Jaroch; Paulina Zofia Gorynska; Krzysztof Gorynski; Marcin Birski; Jacek Furtak; Dariusz Paczkowski; Marek Harat; Barbara Bojko
Journal:  Molecules       Date:  2021-10-10       Impact factor: 4.411

Review 5.  Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.

Authors:  Danyu Du; Chan Liu; Mengyao Qin; Xiao Zhang; Tao Xi; Shengtao Yuan; Haiping Hao; Jing Xiong
Journal:  Acta Pharm Sin B       Date:  2021-09-25       Impact factor: 11.413

6.  Melatonin Regulates the Daily Levels of Plasma Amino Acids, Acylcarnitines, Biogenic Amines, Sphingomyelins, and Hexoses in a Xenograft Model of Triple Negative Breast Cancer.

Authors:  Rubens Paula Junior; Luiz Gustavo de Almeida Chuffa; Vinicius Augusto Simão; Nathália Martins Sonehara; Roger Chammas; Russel J Reiter; Debora Aparecida Pires de Campos Zuccari
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208

7.  Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer.

Authors:  Dehong Li; Yan Lu; Fenghui Zhao; Li Yan; Xingwen Yang; Lianhua Wei; Xiaoyan Yang; Xiumei Yuan; Kehu Yang
Journal:  PeerJ       Date:  2022-10-06       Impact factor: 3.061

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.